ITGDF (Integral Diagnostics) Long-Term Debt: $386.5 Mil (As of Dec. 2025)


ITGDF Integral Diagnostics Ltd ITGDF
84 GF Score
Price $2.61
GF Value $1.17
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Long-Term Debt?

Integral Diagnostics ITGDF 84 Long-Term Debt is $386.5 Mil as of Dec. 2025. GuruFocus rates ITGDF with a GF Score™ of 84/100 and a GF Value™ of $1.17 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Integral Diagnostics's Long-Term Debt for the quarter that ended in Dec. 2025 was $386.5 Mil.

Integral Diagnostics's quarterly Long-Term Debt declined from Dec. 2024 ($321.9 Mil) to Jun. 2025 ($222.2 Mil) but then increased from Jun. 2025 ($222.2 Mil) to Dec. 2025 ($386.5 Mil).

Integral Diagnostics's annual Long-Term Debt declined from Jun. 2023 ($148.4 Mil) to Jun. 2024 ($145.9 Mil) but then increased from Jun. 2024 ($145.9 Mil) to Jun. 2025 ($222.2 Mil).

Integral Diagnostics  (OTCPK:ITGDF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Integral Diagnostics Long-Term Debt Related Terms

Integral Diagnostics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integral Diagnostics Long-Term Debt Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 146.93 152.90 148.42 145.92 222.17

Integral Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.99 145.92 321.90 222.17 386.50
ITGDF
84GF Score
Integral Diagnostics Ltd ITGDF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $386.5 Mil mean?
Integral Diagnostics (ITGDF) has a Long-Term Debt of $386.5 Mil as of Dec. 2025.
Is Integral Diagnostics' Long-Term Debt too high?
Integral Diagnostics' current Long-Term Debt is $386.5 Mil. Overall, Integral Diagnostics has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Long-Term Debt compare to TMO and DHR?
Integral Diagnostics' Long-Term Debt of $386.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Integral Diagnostics's current Long-Term Debt is $386.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ITGDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.17, compared to a current price of $2.61 — trading 123.3% above its estimated fair value. The current Long-Term Debt is $386.5 Mil. Integral Diagnostics' overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Integral Diagnostics (ITGDF), the current Long-Term Debt is $386.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ITGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be overvalued. The current stock price of $2.61 is trading 123.3% above its estimated GF Value™ of $1.17. GuruFocus considers Integral Diagnostics to be Significantly Overvalued.

Key valuation signals for ITGDF:

  • Long-Term Debt: $386.5 Mil
  • GF Value™: $1.17 vs. price of $2.61 (123.3% above fair value)
  • GF Score™: 84/100 with 9 warning signs

No single metric tells the full story. See the ITGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Other Exchanges IDX:Australia
Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
84GF Score

Get the complete analysis for ITGDF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.61
Price
$1.17
GF Value